These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3259730)

  • 21. Cytological characteristics of human glioma-infiltrating lymphocytes stimulated with recombinant interleukin 2 and an anti-CD3 antibody.
    Kikuchi T; Watanabe M; Ohno T
    Jpn J Cancer Res; 1991 Mar; 82(3):339-45. PubMed ID: 1827092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics.
    Zhang JG; Eguchi J; Kruse CA; Gomez GG; Fakhrai H; Schroter S; Ma W; Hoa N; Minev B; Delgado C; Wepsic HT; Okada H; Jadus MR
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):566-575. PubMed ID: 17255279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.
    Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M
    J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
    Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor infiltrating leukocytes (tils) during progressive tumor growth and BCG-mediated tumor regression.
    Steerenberg PA; De Jong WH; Elgersma A; Burger R; Poels LG; Claessen AM; Den Otter W; Ruitenberg EJ
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(4):185-94. PubMed ID: 1980168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms.
    Csiba A; Whitwell HL; Moore M
    Br J Cancer; 1984 Nov; 50(5):699-709. PubMed ID: 6238615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy.
    Ueda R; Ohkusu-Tsukada K; Fusaki N; Soeda A; Kawase T; Kawakami Y; Toda M
    Int J Cancer; 2010 Feb; 126(4):919-29. PubMed ID: 19728337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial meningitis: T cell activation and immunoregulatory CD4+ T cell subset alteration.
    Raziuddin S; el-Awad ME; Mir NA
    J Allergy Clin Immunol; 1991 Jun; 87(6):1115-20. PubMed ID: 1710632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subacute thyroiditis: activated HLA-DR and interferon-gamma expressing T cytotoxic/suppressor cells in thyroid tissue and peripheral blood.
    Karlsson FA; Tötterman TH; Jansson R
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):487-93. PubMed ID: 2957123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.
    Belldegrun A; Muul LM; Rosenberg SA
    Cancer Res; 1988 Jan; 48(1):206-14. PubMed ID: 3257161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An increased number of follicles containing activated CD69+ helper T cells and proliferating CD71+ B cells are found in H. pylori-infected gastric mucosa.
    Terrés AM; Pajares JM
    Am J Gastroenterol; 1998 Apr; 93(4):579-83. PubMed ID: 9576451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC class I and II expression in breast cancer patients.
    Whitford P; George WD; Campbell AM
    Cancer Lett; 1992 Jan; 61(2):157-64. PubMed ID: 1730139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.
    Akbasak A; Oldfield EH; Saris SC
    J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human glioma immunobiology in vitro: implications for immunogene therapy.
    Parney IF; Farr-Jones MA; Chang LJ; Petruk KC
    Neurosurgery; 2000 May; 46(5):1169-77; discussion 1177-8. PubMed ID: 10807250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokines and immunoregulatory molecules in malignant glial neoplasms.
    Schneider J; Hofman FM; Apuzzo ML; Hinton DR
    J Neurosurg; 1992 Aug; 77(2):265-73. PubMed ID: 1625016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
    Engleman EG; Benike CJ; Grumet FC; Evans RL
    J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathyroidal HLA-DR-positive lymphocytes in Hashimoto's disease: increases in CD8 and Leu7 cells.
    Aozasa M; Amino N; Iwatani Y; Tamaki H; Matsuzuka F; Kuma K; Miyai K
    Clin Immunol Immunopathol; 1989 Sep; 52(3):516-22. PubMed ID: 2474398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistological study of mononuclear cell infiltrate in malignant gliomas.
    Rossi ML; Hughes JT; Esiri MM; Coakham HB; Brownell DB
    Acta Neuropathol; 1987; 74(3):269-77. PubMed ID: 3314311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunology of gliomas.
    de Tribolet N
    Childs Nerv Syst; 1989 Apr; 5(2):60-5. PubMed ID: 2660987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
    Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
    Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.